NASH治療薬の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global NASH Therapeutic Drugs Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-16138 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、107ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥504,600 (USD3,480)	▷ お問い合わせ
Multi User	￥756,900 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,009,200 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、NASH治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。NASH治療薬の種類別市場規模（ビタミンE・ピオグリタゾン、オカリバ、エラフィブラノール、セロンサーチブ・セニクリビロック）、用途別市場規模（病院薬局、オンラインプロバイダー、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Allergan Plc (Tobira)、Genfit SA、Bristol Myers Squibb、Zydus Cadila、Galmed Pharmaceuticals、Intercept Pharmaceuticals, Inc.、Gilead Sciences, Inc. ・地域別グローバル市場分析 2015年-2020年 ・NASH治療薬の北米市場（アメリカ、カナダ、メキシコ） ・NASH治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・NASH治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・NASH治療薬の南米市場（ブラジル、アルゼンチン） ・NASH治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ビタミンE・ピオグリタゾン、オカリバ、エラフィブラノール、セロンサーチブ・セニクリビロック ・用途別分析：病院薬局、オンラインプロバイダー、小売薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global NASH Therapeutic Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The NASH Therapeutic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
NASH Therapeutic Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, NASH Therapeutic Drugs market has been segmented into:
Vitamin E and Pioglitazone
Ocaliva
Elafibranor
Selonsertib and Cenicriviroc

By Application, NASH Therapeutic Drugs has been segmented into:
Hospital Pharmacy
Online Provider
Retail Pharmacy

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global NASH Therapeutic Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level NASH Therapeutic Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global NASH Therapeutic Drugs market.

The report offers in-depth assessment of the growth and other aspects of the NASH Therapeutic Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and NASH Therapeutic Drugs Market Share Analysis
NASH Therapeutic Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, NASH Therapeutic Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the NASH Therapeutic Drugs sales, revenue and market share for each player covered in this report.

The major players covered in NASH Therapeutic Drugs are:
Allergan Plc (Tobira)
Genfit SA
Bristol Myers Squibb
Zydus Cadila
Galmed Pharmaceuticals
Intercept Pharmaceuticals, Inc.
Gilead Sciences, Inc.

レポート目次

---

1 NASH Therapeutic Drugs Market Overview
1.1 Product Overview and Scope of NASH Therapeutic Drugs
1.2 Classification of NASH Therapeutic Drugs by Type
1.2.1 Global NASH Therapeutic Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global NASH Therapeutic Drugs Revenue Market Share by Type in 2019
1.2.3 Vitamin E and Pioglitazone
1.2.4 Ocaliva
1.2.5 Elafibranor
1.2.6 Selonsertib and Cenicriviroc
1.3 Global NASH Therapeutic Drugs Market by Application
1.3.1 Overview: Global NASH Therapeutic Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacy
1.3.3 Online Provider
1.3.4 Retail Pharmacy
1.4 Global NASH Therapeutic Drugs Market by Regions
1.4.1 Global NASH Therapeutic Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of NASH Therapeutic Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) NASH Therapeutic Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) NASH Therapeutic Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) NASH Therapeutic Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) NASH Therapeutic Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) NASH Therapeutic Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Allergan Plc (Tobira)
2.1.1 Allergan Plc (Tobira) Details
2.1.2 Allergan Plc (Tobira) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Allergan Plc (Tobira) SWOT Analysis
2.1.4 Allergan Plc (Tobira) Product and Services
2.1.5 Allergan Plc (Tobira) NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Genfit SA
2.2.1 Genfit SA Details
2.2.2 Genfit SA Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Genfit SA SWOT Analysis
2.2.4 Genfit SA Product and Services
2.2.5 Genfit SA NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol Myers Squibb
2.3.1 Bristol Myers Squibb Details
2.3.2 Bristol Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bristol Myers Squibb SWOT Analysis
2.3.4 Bristol Myers Squibb Product and Services
2.3.5 Bristol Myers Squibb NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Zydus Cadila
2.4.1 Zydus Cadila Details
2.4.2 Zydus Cadila Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Zydus Cadila SWOT Analysis
2.4.4 Zydus Cadila Product and Services
2.4.5 Zydus Cadila NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Galmed Pharmaceuticals
2.5.1 Galmed Pharmaceuticals Details
2.5.2 Galmed Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Galmed Pharmaceuticals SWOT Analysis
2.5.4 Galmed Pharmaceuticals Product and Services
2.5.5 Galmed Pharmaceuticals NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Intercept Pharmaceuticals, Inc.
2.6.1 Intercept Pharmaceuticals, Inc. Details
2.6.2 Intercept Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Intercept Pharmaceuticals, Inc. SWOT Analysis
2.6.4 Intercept Pharmaceuticals, Inc. Product and Services
2.6.5 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Gilead Sciences, Inc.
2.7.1 Gilead Sciences, Inc. Details
2.7.2 Gilead Sciences, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Gilead Sciences, Inc. SWOT Analysis
2.7.4 Gilead Sciences, Inc. Product and Services
2.7.5 Gilead Sciences, Inc. NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global NASH Therapeutic Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 NASH Therapeutic Drugs Players Market Share
3.2.2 Top 10 NASH Therapeutic Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global NASH Therapeutic Drugs Revenue and Market Share by Regions
4.2 North America NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
4.5 South America NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
5 North America NASH Therapeutic Drugs Revenue by Countries
5.1 North America NASH Therapeutic Drugs Revenue by Countries (2015-2020)
5.2 USA NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
6 Europe NASH Therapeutic Drugs Revenue by Countries
6.1 Europe NASH Therapeutic Drugs Revenue by Countries (2015-2020)
6.2 Germany NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
6.3 UK NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
6.4 France NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific NASH Therapeutic Drugs Revenue by Countries
7.1 Asia-Pacific NASH Therapeutic Drugs Revenue by Countries (2015-2020)
7.2 China NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
7.5 India NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
8 South America NASH Therapeutic Drugs Revenue by Countries
8.1 South America NASH Therapeutic Drugs Revenue by Countries (2015-2020)
8.2 Brazil NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue NASH Therapeutic Drugs by Countries
9.1 Middle East & Africa NASH Therapeutic Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global NASH Therapeutic Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global NASH Therapeutic Drugs Market Forecast by Type (2019-2024)
10.3 Vitamin E and Pioglitazone Revenue Growth Rate (2015-2025)
10.4 Ocaliva Revenue Growth Rate (2015-2025)
10.5 Elafibranor Revenue Growth Rate (2015-2025)
10.6 Selonsertib and Cenicriviroc Revenue Growth Rate (2015-2025)
11 Global NASH Therapeutic Drugs Market Segment by Application
11.1 Global NASH Therapeutic Drugs Revenue Market Share by Application (2015-2020)
11.2 NASH Therapeutic Drugs Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacy Revenue Growth (2015-2020)
11.4 Online Provider Revenue Growth (2015-2020)
11.5 Retail Pharmacy Revenue Growth (2015-2020)
12 Global NASH Therapeutic Drugs Market Size Forecast (2021-2025)
12.1 Global NASH Therapeutic Drugs Market Size Forecast (2021-2025)
12.2 Global NASH Therapeutic Drugs Market Forecast by Regions (2021-2025)
12.3 North America NASH Therapeutic Drugs Revenue Market Forecast (2021-2025)
12.4 Europe NASH Therapeutic Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific NASH Therapeutic Drugs Revenue Market Forecast (2021-2025)
12.6 South America NASH Therapeutic Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa NASH Therapeutic Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global NASH Therapeutic Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of NASH Therapeutic Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global NASH Therapeutic Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market NASH Therapeutic Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Allergan Plc (Tobira) Corporate Information, Location and Competitors
Table 6. Allergan Plc (Tobira) NASH Therapeutic Drugs Major Business
Table 7. Allergan Plc (Tobira) NASH Therapeutic Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Allergan Plc (Tobira) SWOT Analysis
Table 9. Allergan Plc (Tobira) NASH Therapeutic Drugs Product and Solutions
Table 10. Allergan Plc (Tobira) NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Genfit SA Corporate Information, Location and Competitors
Table 12. Genfit SA NASH Therapeutic Drugs Major Business
Table 13. Genfit SA NASH Therapeutic Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Genfit SA SWOT Analysis
Table 15. Genfit SA NASH Therapeutic Drugs Product and Solutions
Table 16. Genfit SA NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Bristol Myers Squibb Corporate Information, Location and Competitors
Table 18. Bristol Myers Squibb NASH Therapeutic Drugs Major Business
Table 19. Bristol Myers Squibb NASH Therapeutic Drugs Total Revenue (USD Million) (2017-2018)
Table 20. Bristol Myers Squibb SWOT Analysis
Table 21. Bristol Myers Squibb NASH Therapeutic Drugs Product and Solutions
Table 22. Bristol Myers Squibb NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Zydus Cadila Corporate Information, Location and Competitors
Table 24. Zydus Cadila NASH Therapeutic Drugs Major Business
Table 25. Zydus Cadila NASH Therapeutic Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Zydus Cadila SWOT Analysis
Table 27. Zydus Cadila NASH Therapeutic Drugs Product and Solutions
Table 28. Zydus Cadila NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Galmed Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Galmed Pharmaceuticals NASH Therapeutic Drugs Major Business
Table 31. Galmed Pharmaceuticals NASH Therapeutic Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Galmed Pharmaceuticals SWOT Analysis
Table 33. Galmed Pharmaceuticals NASH Therapeutic Drugs Product and Solutions
Table 34. Galmed Pharmaceuticals NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Intercept Pharmaceuticals, Inc. Corporate Information, Location and Competitors
Table 36. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Major Business
Table 37. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Total Revenue (USD Million) (2017-2018)
Table 38. Intercept Pharmaceuticals, Inc. SWOT Analysis
Table 39. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Product and Solutions
Table 40. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Gilead Sciences, Inc. Corporate Information, Location and Competitors
Table 42. Gilead Sciences, Inc. NASH Therapeutic Drugs Major Business
Table 43. Gilead Sciences, Inc. NASH Therapeutic Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Gilead Sciences, Inc. SWOT Analysis
Table 45. Gilead Sciences, Inc. NASH Therapeutic Drugs Product and Solutions
Table 46. Gilead Sciences, Inc. NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global NASH Therapeutic Drugs Revenue (Million USD) by Players (2015-2020)
Table 48. Global NASH Therapeutic Drugs Revenue Share by Players (2015-2020)
Table 49. Global NASH Therapeutic Drugs Revenue (Million USD) by Regions (2015-2020)
Table 50. Global NASH Therapeutic Drugs Revenue Market Share by Regions (2015-2020)
Table 51. North America NASH Therapeutic Drugs Revenue by Countries (2015-2020)
Table 52. North America NASH Therapeutic Drugs Revenue Market Share by Countries (2015-2020)
Table 53. Europe NASH Therapeutic Drugs Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific NASH Therapeutic Drugs Revenue (Million USD) by Countries (2015-2020)
Table 55. South America NASH Therapeutic Drugs Revenue by Countries (2015-2020)
Table 56. South America NASH Therapeutic Drugs Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa NASH Therapeutic Drugs Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa NASH Therapeutic Drugs Revenue Market Share by Countries (2015-2020)
Table 59. Global NASH Therapeutic Drugs Revenue (Million USD) by Type (2015-2020)
Table 60. Global NASH Therapeutic Drugs Revenue Share by Type (2015-2020)
Table 61. Global NASH Therapeutic Drugs Revenue Forecast by Type (2021-2025)
Table 62. Global NASH Therapeutic Drugs Revenue by Application (2015-2020)
Table 63. Global NASH Therapeutic Drugs Revenue Share by Application (2015-2020)
Table 64. Global NASH Therapeutic Drugs Revenue Forecast by Application (2021-2025)
Table 65. Global NASH Therapeutic Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. NASH Therapeutic Drugs Picture
Figure 2. Global NASH Therapeutic Drugs Revenue Market Share by Type in 2019
Figure 3. Vitamin E and Pioglitazone Picture
Figure 4. Ocaliva Picture
Figure 5. Elafibranor Picture
Figure 6. Selonsertib and Cenicriviroc Picture
Figure 7. NASH Therapeutic Drugs Revenue Market Share by Application in 2019
Figure 8. Hospital Pharmacy Picture
Figure 9. Online Provider Picture
Figure 10. Retail Pharmacy Picture
Figure 11. Global NASH Therapeutic Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America NASH Therapeutic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe NASH Therapeutic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific NASH Therapeutic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America NASH Therapeutic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa NASH Therapeutic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global NASH Therapeutic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global NASH Therapeutic Drugs Revenue Share by Players in 2019
Figure 19. Global Top 5 Players NASH Therapeutic Drugs Revenue Market Share in 2019
Figure 20. Global Top 10 Players NASH Therapeutic Drugs Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global NASH Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global NASH Therapeutic Drugs Revenue Market Share by Regions (2015-2020)
Figure 24. Global NASH Therapeutic Drugs Revenue Market Share by Regions in 2018
Figure 25. North America NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 26. Europe NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 28. South America NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 30. North America NASH Therapeutic Drugs Revenue Market Share by Countries (2015-2020)
Figure 31. North America NASH Therapeutic Drugs Revenue Market Share by Countries in 2019
Figure 32. USA NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Canada NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 34. Mexico NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 35. Europe NASH Therapeutic Drugs Revenue Market Share by Countries (2015-2020)
Figure 36. Europe NASH Therapeutic Drugs Revenue Market Share by Countries in 2019
Figure 37. Germany NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 38. UK NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 39. France NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 40. Russia NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 41. Italy NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific NASH Therapeutic Drugs Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific NASH Therapeutic Drugs Revenue Market Share by Countries in 2019
Figure 44. China NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Japan NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Korea NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 47. India NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 49. South America NASH Therapeutic Drugs Revenue Market Share by Countries (2015-2020)
Figure 50. South America NASH Therapeutic Drugs Revenue Market Share by Countries in 2019
Figure 51. Brazil NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 52. Argentina NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa NASH Therapeutic Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa NASH Therapeutic Drugs Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 56. UAE NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 57. Egypt NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 58. South Africa NASH Therapeutic Drugs Revenue and Growth Rate (2015-2020)
Figure 59. Global NASH Therapeutic Drugs Revenue Share by Type (2015-2020)
Figure 60. Global NASH Therapeutic Drugs Revenue Share by Type in 2019
Figure 61. Global NASH Therapeutic Drugs Market Share Forecast by Type (2021-2025)
Figure 62. Global Vitamin E and Pioglitazone Revenue Growth Rate (2015-2020)
Figure 63. Global Ocaliva Revenue Growth Rate (2015-2020)
Figure 64. Global Elafibranor Revenue Growth Rate (2015-2020)
Figure 65. Global Selonsertib and Cenicriviroc Revenue Growth Rate (2015-2020)
Figure 66. Global NASH Therapeutic Drugs Revenue Share by Application (2015-2020)
Figure 67. Global NASH Therapeutic Drugs Revenue Share by Application in 2019
Figure 68. Global NASH Therapeutic Drugs Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospital Pharmacy Revenue Growth Rate (2015-2020)
Figure 70. Global Online Provider Revenue Growth Rate (2015-2020)
Figure 71. Global Retail Pharmacy Revenue Growth Rate (2015-2020)
Figure 72. Global NASH Therapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global NASH Therapeutic Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global NASH Therapeutic Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America NASH Therapeutic Drugs Revenue Market Forecast (2021-2025)
Figure 76. Europe NASH Therapeutic Drugs Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific NASH Therapeutic Drugs Revenue Market Forecast (2021-2025)
Figure 78. South America NASH Therapeutic Drugs Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa NASH Therapeutic Drugs Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---